Hainan Shuangcheng Pharmaceuticals Hits Day High with 10.02% Surge

Hainan Shuangcheng Pharmaceuticals Co., Ltd. has experienced a significant surge in its stock price, gaining 10.02% on June 29, 2026. The stock reached an intraday high of CNY 9.11, reflecting strong performance relative to the broader market, as the China Shanghai Composite index only increased by 1.16% on the same day. In terms of performance metrics, Hainan Shuangcheng has shown resilience over various time frames. Over the past year, the stock has delivered a return of 25.31%, outperforming the China Shanghai Composite, which recorded an 18.97% increase. Year-to-date, the stock has risen by 30.89%, significantly higher than the composite's 2.65% gain. The company's financial health is underscored by impressive growth in net sales, which reached CNY 156.3 million, marking a 92.49% increase. Additionally, the operating cash flow hit a record high of CNY 86.49 million, while net profit for the half-year stood at CNY 25.32 million. With a market capitalization of CNY 3,576 million, Hainan Shuangcheng continues to solidify its position in the pharmaceuticals and biotechnology sector.